Hematopoietic Stem Cell Transplantation: Current Trends and Future Perspectives

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Hematology and Immunology".

Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 176

Special Issue Editors


E-Mail Website
Guest Editor
Department of Onco-Hematology, Hematology and BMT Unit, University Hospital of Parma, Parma, Italy
Interests: haploidentical HSCT; infectious complications; graft manipulation; immune reconstitution; GVHD
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of Pediatric Hematology and Oncology, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00100 Rome, Italy
Interests: allogeneic stem cell transplantation; immune reconstitution; infectious and immunological complications after Hsct

Special Issue Information

Dear Colleagues,

Hematopoietic stem cell transplantation (HSCT) was first explored for use in humans in the 1950s. Since then, the use of allogeneic and autologous stem cell transplants has increased worldwide.  Due to emerging therapies (drugs, carT, …), in recent years the HSCT has lost indication in some diseases (like B-ALL or lymphoproliferative disorders).

Conversely, its role is importantly changing in terms of indication and eligibility in other diseases, like T-ALL, autoimmune disease, and/or hemoglobinopathies (above all sickle cell disease) due to a better understanding of biology of these disease, but also biology of transplant. The knowledge and progresses made in the field of therapy-as-a-bridge-to-transplant, HLA compatibility, conditioning regimens, manipulation of the graft (above all in the haplo setting), graft-versus-host disease (GVHD) prophylaxis and treatment, and in management of complications, like VOD, infections, and/or organ toxicity, have significantly improved the outcome of transplants, even in disease types in which transplant-related mortality was high.

This Special Issue will focus on the role of autologous and allogenic HSCT in the new era of Car-T cell, gene therapy, “personalized” therapy, and precision medicine, with new evidence and indications.

For this Special Issue, original research articles, narrative reviews, scoping reviews, and systematic reviews with meta-analysis are invited to help improve clinical management.

Dr. Lucia Prezioso
Dr. Federica Galaverna
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • allogenic stem cell transplantation
  • GVHD, infections
  • stem cell manipulation
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • lymphoproliferative disorders
  • hemoglobinopathies
  • autoimmune disease
  • immune reconstitution
  • minimal residual disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop